Results 141 to 150 of about 4,213 (213)

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. [PDF]

Obstet Gynecol, 2019
Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA.   +7 more
europepmc   +1 more source

What Women Want? The State of the Art regarding the Treatment of Young Women with Hypoactive Sexual Desire Disorder.

Pharmacology
de Oliveira L, Vignozzi L, Giraldi A, Varod S, Corona G, Reisman Y.   +5 more
europepmc   +1 more source

Role of hormones in hypoactive sexual desire disorder and current treatment. [PDF]

J Turk Ger Gynecol Assoc, 2017
AlAwlaqi A, Amor H, Hammadeh ME.
europepmc   +1 more source

New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin. [PDF]

Int J Womens Health, 2017
Jayne CJ, Heard MJ, Zubair S, Johnson DL.   +3 more
europepmc   +1 more source

A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes. [PDF]

Diabetes Ther, 2017
Rochester-Eyeguokan C, Meade L.
europepmc   +1 more source

Flibanserin for hypoactive sexual desire disorder: place in therapy. [PDF]

Ther Adv Chronic Dis, 2017
Gelman F, Atrio J.
europepmc   +1 more source

Transdermal Testosterone in Female Hypoactive Sexual Desire Disorder: A Rapid Qualitative Systematic Review Using Grading of Recommendations Assessment, Development and Evaluation. [PDF]

Cureus, 2018
Ganesan K, Habboush Y, Sultan S.
europepmc   +1 more source